Humasis replaces Cellivery in the KOSDAQ150 Index - the timing of the change is currently uncertain. Humasis was a potential add in June - the stock went ex-scrip on Friday and was limit up.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.